Search Results - "Bowman, Cindy M"

Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site by Bradley, Todd, Fera, Daniela, Bhiman, Jinal, Eslamizar, Leila, Lu, Xiaozhi, Anasti, Kara, Zhang, Ruijung, Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy M., Stolarchuk, Christina, Lloyd, Krissey E., Parks, Robert, Eaton, Amanda, Foulger, Andrew, Nie, Xiaoyan, Karim, Salim S. Abdool, Barnett, Susan, Kelsoe, Garnett, Kepler, Thomas B., Alam, S. Munir, Montefiori, David C., Moody, M. Anthony, Liao, Hua-Xin, Morris, Lynn, Santra, Sampa, Harrison, Stephen C., Haynes, Barton F.

“…Antibodies that neutralize autologous transmitted/founder (TF) HIV occur in most HIV-infected individuals and can evolve to neutralization breadth. Autologous…”
Get full text

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity by Bradley, Todd, Trama, Ashley, Tumba, Nancy, Gray, Elin, Lu, Xiaozhi, Madani, Navid, Jahanbakhsh, Fatemeh, Eaton, Amanda, Xia, Shi-Mao, Parks, Robert, Lloyd, Krissey E., Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy M., Barnett, Susan, Abdool-Karim, Salim S., Boyd, Scott D., Melillo, Bruno, Smith, Amos B., Sodroski, Joseph, Kepler, Thomas B., Alam, S.Munir, Gao, Feng, Bonsignori, Mattia, Liao, Hua-Xin, Moody, M. Anthony, Montefiori, David, Santra, Sampa, Morris, Lynn, Haynes, Barton F.

“…Most HIV-1 vaccines elicit neutralizing antibodies that are active against highly sensitive (tier-1) viruses or rare cases of vaccine-matched…”
Get full text

Immune checkpoint modulation enhances HIV-1 antibody induction by Bradley, Todd, Kuraoka, Masayuki, Yeh, Chen-Hao, Tian, Ming, Chen, Huan, Cain, Derek W., Chen, Xuejun, Cheng, Cheng, Ellebedy, Ali H., Parks, Robert, Barr, Maggie, Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy M., Bouton-Verville, Hilary, Santra, Sampa, Wiehe, Kevin, Lewis, Mark G., Ogbe, Ane, Borrow, Persephone, Montefiori, David, Bonsignori, Mattia, Anthony Moody, M., Verkoczy, Laurent, Saunders, Kevin O., Ahmed, Rafi, Mascola, John R., Kelsoe, Garnett, Alt, Frederick W., Haynes, Barton F.

“…Eliciting protective titers of HIV-1 broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development, but current vaccine strategies have yet to…”
Get full text

HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques by Han, Qifeng, Williams, Wilton B, Saunders, Kevin O, Seaton, Kelly E, Wiehe, Kevin J, Vandergrift, Nathan, Von Holle, Tarra A, Trama, Ashley M, Parks, Robert J, Luo, Kan, Gurley, Thaddeus C, Kepler, Thomas B, Marshall, Dawn J, Montefiori, David C, Sutherland, Laura L, Alam, Munir S, Whitesides, John F, Bowman, Cindy M, Permar, Sallie R, Graham, Barney S, Mascola, John R, Seed, Patrick C, Van Rompay, Koen K A, Tomaras, Georgia D, Moody, M Anthony, Haynes, Barton F

“…Dominant antibody responses in vaccinees who received the HIV-1 multiclade (A, B, and C) envelope (Env) DNA/recombinant adenovirus virus type 5 (rAd5) vaccine…”
Get full text

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques by Luo, Kan, Liao, Hua-Xin, Zhang, Ruijun, Easterhoff, David, Wiehe, Kevin, Gurley, Thaddeus C, Armand, Lawrence C, Allen, Ashley A, Von Holle, Tarra A, Marshall, Dawn J, Whitesides, John F, Pritchett, Jamie, Foulger, Andrew, Hernandez, Giovanna, Parks, Robert, Lloyd, Krissey E, Stolarchuk, Christina, Sawant, Sheetal, Peel, Jessica, Yates, Nicole L, Dunford, Erika, Arora, Sabrina, Wang, Amy, Bowman, Cindy M, Sutherland, Laura L, Scearce, Richard M, Xia, Shi-Mao, Bonsignori, Mattia, Pollara, Justin, Edwards, R Whitney, Santra, Sampa, Letvin, Norman L, Tartaglia, James, Francis, Donald, Sinangil, Faruk, Lee, Carter, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Rerks-Ngarm, Supachai, Michael, Nelson L, Kim, Jerome H, Alam, S Munir, Vandergrift, Nathan A, Ferrari, Guido, Montefiori, David C, Tomaras, Georgia D, Haynes, Barton F, Moody, M Anthony

“…The ALVAC prime/ALVAC + AIDSVAX B/E boost RV144 vaccine trial induced an estimated 31% efficacy in a low-risk cohort where HIV‑1 exposures were likely at…”
Get full text

HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism by Bradley, Todd, Yang, Guang, Ilkayeva, Olga, Holl, T Matt, Zhang, Ruijun, Zhang, Jinsong, Santra, Sampa, Fox, Christopher B, Reed, Steve G, Parks, Robert, Bowman, Cindy M, Bouton-Verville, Hilary, Sutherland, Laura L, Scearce, Richard M, Vandergrift, Nathan, Kepler, Thomas B, Moody, M Anthony, Liao, Hua-Xin, Alam, S Munir, McLendon, Roger, Everitt, Jeffrey I, Newgard, Christopher B, Verkoczy, Laurent, Kelsoe, Garnett, Haynes, Barton F

“…The HIV-1 envelope protein (Env) has evolved to subvert the host immune system, hindering viral control by the host. The tryptophan metabolic enzyme…”
Get full text

Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice by Wiehe, Kevin, Nicely, Nathan I, Lockwood, Bradley, Kuraoka, Masayuki, Anasti, Kara, Arora, Sabrina, Bowman, Cindy M, Stolarchuk, Christina, Parks, Robert, Lloyd, Krissey E, Xia, Shi-Mao, Duffy, Ryan, Shen, Xiaoying, Kyratsous, Christos A, Macdonald, Lynn E, Murphy, Andrew J, Scearce, Richard M, Moody, M Anthony, Alam, S Munir, Verkoczy, Laurent, Tomaras, Georgia D, Kelsoe, Garnett, Haynes, Barton F

“…In the RV144 gp120 HIV vaccine trial, decreased transmission risk was correlated with Abs that reacted with a linear epitope at a lysine residue at position…”
Get full text

Immunodominance of antibody recognition of the HIV envelope second variable region in immunoglobulin humanized mice by Wiehe, Kevin, Nicely, Nathan I., Lockwood, Bradley, Kuraoka, Masayuki, Anasti, Kara, Arora, Sabrina, Bowman, Cindy M., Stolarchuk, Christina, Parks, Robert, Lloyd, Krissey E., Xia, Shi-Mao, Duffy, Ryan, Shen, Xiaoying, Kyratsous, Christos A., Macdonald, Lynn E., Murphy, Andrew J., Scearce, Richard M., Moody, M. Anthony, Alam, S. Munir, Verkoczy, Laurent, Tomaras, Georgia D., Kelsoe, Garnett, Haynes, Barton F.

“…In the RV144 gp120 HIV vaccine trial, decreased transmission risk was correlated with antibodies that reacted with a linear epitope at a lysine at position 169…”
Get full text